Purchase Order 75F40122P00174

The U.S. Food and Drug Administration (FDA) awarded a firm fixed-price purchase order valued at $40,642.58 to Bio-Rad Laboratories, Inc. to procure a CDER-2023-118721-SS-CHEMIDOC MP Imaging System on a sole source basis. The contract has a period of performance from July 25, 2023 through July 24, 2024. Bio-Rad Laboratories will deliver the requested imaging system to the FDA location in Hercules, California. This award satisfies FDA's Office of Acquisition and Grants Services requirement under...

Bio-Rad Laboratories Inc., a global manufacturer of life science research and clinical diagnostic products headquartered in Hercules, California, was awarded a $12,000 firm fixed-price purchase order for a GelDoc GO Gel Imaging System Bundle by the Pacific West Area (a civilian federal agency) on July 31, 2024, with an ultimate completion date of August 31, 2024. The contract was not subject to a small business set-aside designation, reflecting Bio-Rad's status as a large business capable of...

The FDA Office of Acquisition and Grants Services awarded a purchase order to Bio-Rad Laboratories, Inc. for a multiplex system upgrade (brand name or equal) plus four option years of preventative maintenance agreement, with a ceiling value of $68,039.00 and an award date of June 28, 2021. The ultimate completion date is July 29, 2026. Place of performance is Rodeo, California. The contract is firm fixed price with no set-aside used, though the originating opportunity (posted January 19, 2021)...

The Food and Drug Administration awarded a $17,400 firm fixed-price purchase order to Bio-Rad Laboratories, Inc., Life Science Group Division, on May 26, 2016, for delivery by May 31, 2017. This contract, issued without a small business set-aside designation, represents procurement of specialized laboratory equipment and supplies from the vendor's Hercules, California manufacturing facility. Bio-Rad Laboratories is a global leader in life science research and clinical diagnostics products,...

This federal contract award is for the purchase of an imaging system for the documentation of DNA/protein gels and blotting applications. The $23,400.00 firm fixed-price contract was awarded to Bio Rad Laboratories Inc., operating as the Bio-Rad Diagnostics Division, by the Pacific West Area of the U.S. Department of Agriculture. The imaging system must be compatible with a variety of gel stains and technologies, have onboard processing capabilities, and be upgradeable for multiplex fluorescence...

This federal contract award is for the procurement of a BIO RAD GELDOC GO GEL IMAGING SYSTEM WITH IMAGE LAB TOUCH by the U.S. government agency Plains Area, which is part of the Department of Defense. The contract was awarded to Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics equipment manufacturing, on September 15, 2020, with a ceiling value of $11,191.00 and a completion date of March 31, 2021. The contract is a firm fixed-price purchase order and...

The Food and Drug Administration awarded a purchase order to Bio-Rad Laboratories, Inc. for a CFX Opus DeepWell Real-Time PCR System valued at $27,499.00, with an award date of September 8, 2023 and ultimate completion date of September 29, 2024. The order covers acquisition of a quantitative real-time PCR instrument for molecular analysis applications, with place of performance in Rodeo, California. Bio-Rad, a for-profit life science research and clinical diagnostic equipment manufacturer,...

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for a Bio-Rad ChemiDoc Touch imaging system valued at $29,040.00 on September 20, 2016, with ultimate completion on May 21, 2021. The order was funded by de-obligation of FY2016 expiring funds. Place of performance is Rodeo, California. The purchase order carried firm fixed-price terms and no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $29,040 on July 21, 2016, for Bio-Rad ChemiDoc Touch imaging equipment. No set-aside was used. Performance is at Bio-Rad's facility in Rodeo, California. The order carries a firm fixed-price structure and an ultimate completion date of January 20, 2021. The award represents a de-obligation of expiring FY2016 funds for laboratory instrumentation supporting biomedical research operations.</p>

The Department of Health and Human Services Food and Drug Administration has awarded a $105,915.60 firm fixed price purchase order to Bio-Rad Laboratories, Inc. for a Fast Protein Liquid Chromatography (FPLC) System. The contract has a completion date of September 30, 2024 and does not involve any set-aside designation. Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics equipment and supplies. As the parent company, Bio-Rad has a substantial history...